NGL Fine-Chem Limited (NSE:NGLFINE)
2,229.80
+97.20 (4.56%)
Apr 6, 2026, 3:29 PM IST
NGL Fine-Chem Revenue
NGL Fine-Chem had revenue of 1.28B INR in the quarter ending December 31, 2025, with 43.11% growth. This brings the company's revenue in the last twelve months to 4.47B, up 19.85% year-over-year. In the fiscal year ending March 31, 2025, NGL Fine-Chem had annual revenue of 3.68B with 8.73% growth.
Revenue (ttm)
4.47B
Revenue Growth
+19.85%
P/S Ratio
3.08
Revenue / Employee
8.59M
Employees
520
Market Cap
13.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.68B | 295.68M | 8.73% |
| Mar 31, 2024 | 3.39B | 606.08M | 21.79% |
| Mar 31, 2023 | 2.78B | -394.22M | -12.42% |
| Mar 31, 2022 | 3.18B | 595.28M | 23.08% |
| Mar 31, 2021 | 2.58B | 1.06B | 70.07% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Cipla | 279.67B |
| Apollo Hospitals Enterprise | 242.15B |
| Divi's Laboratories | 103.14B |
| Shalby | 11.19B |
| Windlas Biotech | 8.68B |
| Ind-Swift Laboratories | 5.94B |
| Beta Drugs | 3.85B |
NGL Fine-Chem News
- 4 months ago - NGL Fine-Chem Ltd (BOM:524774) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 4 months ago - Q2 2026 Ngl Fine Chem Ltd Earnings Call Transcript - GuruFocus
- 1 year ago - NGL Fine-Chem Ltd (BOM:524774) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus
- 1 year ago - Q2 2025 Ngl Fine Chem Ltd Earnings Call Transcript - GuruFocus